Articles published by AKAMPION
From AKAMPION
Via GlobeNewswire
From AKAMPION
Via GlobeNewswire
From AKAMPION
Via GlobeNewswire
From AKAMPION
Via GlobeNewswire
Pan Cancer T Appoints Dr. Rachel Abbott as Chief Scientific Officer
January 17, 2023
From AKAMPION
Via GlobeNewswire
ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002
January 17, 2023
From AKAMPION
Via GlobeNewswire
Rewind Therapeutics Appoints Dr. Stephen Burbidge to its Management Team
November 29, 2022
From AKAMPION
Via GlobeNewswire
HpVac Appoints Joana Vitte, MD, PhD, as Chief Scientific Officer
November 23, 2022
From AKAMPION
Via GlobeNewswire
From AKAMPION
Via GlobeNewswire
ImmunOs Therapeutics´ Lead Program Shows Strong Anti-Tumor Activity In Vivo and In Vitro
November 15, 2022
From AKAMPION
Via GlobeNewswire
From AKAMPION
Via GlobeNewswire
ImmunOs Therapeutics Announces Appointment of Joseph Leveque, MD, to its Board of Directors
October 04, 2022
From AKAMPION
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.